company background image
LUMITO logo

Lumito NGM:LUMITO Stock Report

Last Price

SEK 0.58

Market Cap

SEK 129.5m

7D

34.8%

1Y

-47.8%

Updated

16 Jun, 2025

Data

Company Financials

Lumito (LUMITO) Stock Overview

Engages in the medical research and development of imaging technology in Sweden. More details

LUMITO fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

LUMITO Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Lumito AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for Lumito
Historical stock prices
Current Share PriceSEK 0.58
52 Week HighSEK 0
52 Week LowSEK 0
Beta0.63
1 Month Change47.09%
3 Month Change22.32%
1 Year Change-47.85%
3 Year Change-42.93%
5 Year Change-86.07%
Change since IPO-71.52%

Recent News & Updates

Health Check: How Prudently Does Lumito (NGM:LUMITO) Use Debt?

Jan 08
Health Check: How Prudently Does Lumito (NGM:LUMITO) Use Debt?

Lumito (NGM:LUMITO) Has Debt But No Earnings; Should You Worry?

Sep 18
Lumito (NGM:LUMITO) Has Debt But No Earnings; Should You Worry?

Shareholder Returns

LUMITOSE Medical EquipmentSE Market
7D34.8%-2.8%-1.8%
1Y-47.8%-8.7%-3.1%

Return vs Industry: LUMITO underperformed the Swedish Medical Equipment industry which returned -9.4% over the past year.

Return vs Market: LUMITO underperformed the Swedish Market which returned -4.1% over the past year.

Price Volatility

Is LUMITO's price volatile compared to industry and market?
LUMITO volatility
LUMITO Average Weekly Movement12.1%
Medical Equipment Industry Average Movement8.6%
Market Average Movement6.8%
10% most volatile stocks in SE Market13.4%
10% least volatile stocks in SE Market4.1%

Stable Share Price: LUMITO's share price has been volatile over the past 3 months compared to the Swedish market.

Volatility Over Time: LUMITO's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Swedish stocks.

About the Company

FoundedEmployeesCEOWebsite
201010Sanna Wallenborglumito.se

Lumito AB (publ) engages in the medical research and development of imaging technology in Sweden. It offers tissue analysis system based on upconverting nanoparticles, including SCIZYS system combining labeling and imaging technologies to locate and measure biomarkers in tissue samples. The company’s technology addresses challenges in various application areas, such as drug development, academic research, and clinical diagnostics.

Lumito AB (publ) Fundamentals Summary

How do Lumito's earnings and revenue compare to its market cap?
LUMITO fundamental statistics
Market capSEK 129.49m
Earnings (TTM)-SEK 46.25m
Revenue (TTM)SEK 81.51k
1,895x
P/S Ratio
-3.3x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LUMITO income statement (TTM)
RevenueSEK 81.51k
Cost of Revenue-SEK 2.39m
Gross ProfitSEK 2.47m
Other ExpensesSEK 48.72m
Earnings-SEK 46.25m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.17
Gross Margin3,028.48%
Net Profit Margin-56,749.18%
Debt/Equity Ratio0%

How did LUMITO perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/16 13:15
End of Day Share Price 2025/06/16 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Lumito AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.